Senior Process Engineer - Biotech/Pharma (Hybrid)

PSC Biotech Corporation; Dublin; Hybrid; EUR 90,000 - 130,000; Full time

Benefits offered by this job

Hybrid work schedule

In-house training & mentorship

Exposure to top pharma clients

Job summary

PSC Biotech Corporation seeks a Senior Specialist - Engineering to ensure compliant design, construction, qualification and operation of a new state-of-the-art facility in Ireland. The role will lead technology transfer, process development and continuous improvement across multi-disciplinary teams.

The ideal candidate has 5–7 years of relevant experience in pharma/biotech and solid knowledge of GMP, CQV, and regulatory filings. Hybrid onsite requirement and early 2027 start are specified.

Qualifications

• Minimum 5 years' (MSc) or 7 years' (BSc) directly related experience in academia, pharma or biotech.
• Knowledge of current regulatory requirements and GMP.

Responsibilities

• Lead design, construction, qualification and operation of the new facility during initial phase.
• Support upstream & downstream equipment design, qualification and tech transfer.
• Apply Lean Six Sigma tools and lead problem solving & risk assessment (FMEA).
• Author batch docs, technical reports and regulatory submissions.
• Collaborate with manufacturing science, quality, analytics and regulatory teams for process improvements.

Skills

Process Engineering

Pharma manufacturing

Regulatory compliance

Lean Six Sigma

Data analysis

Statistical methods

Education

Bachelor's degree in Biological Sciences/Chemical Engineering

Master's degree (MSc) in related field

Tools

JMP

Design Expert

Job description

PSC Biotech Corporation seeks a Senior Specialist - Engineering to ensure compliant design, construction, qualification and operation of a new state-of-the-art facility in Ireland. The role will lead technology transfer, process development and continuous improvement across multi-disciplinary teams.

The ideal candidate has 5–7 years of relevant experience in pharma/biotech and solid knowledge of GMP, CQV, and regulatory filings. Hybrid onsite requirement and early 2027 start are specified.